Surgical Instrument Tracking Systems Market Regional Outlook, Competitive Strategies Factors, Contributing To Growth And Forecast 2025


4 February 2020 - Global Surgical Instrument Tracking Systems Market was valued at over USD 83.5 million in 2015 and is anticipated to rise at over 19.0% during the forecast period. The major factors, which contribute to the growth of this market are growing incidence of hospital acquired infections and instrument misplacement. In the U.S., nearly 90,000 people die every year due to hospital-acquired infections, based on a data by CDC. In order to prevent these infections arising out of instrument contamination, instrument tracking system is highly useful. It is also used for inventory management to enhance the efficiency of the staff.

            

Rising prevalence of retained surgical equipment cases is another factor which is expected to contribute to the demand for surgical instrument tracking systems in the coming years. The fatality rate of retained surgical instruments accounted for nearly 2%, according to a study by the National Center for Biotechnology Information. Technological advancements in the field of surgical instrument tracking systems, such as RFID, 2D bar codes further boost the growth of this market.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/surgical-instrument-tracking-systems-market

Product Insights

Based on the product, the market is classified into services, hardware and software. Software held the largest market share in 2016 and is projected to witness lucrative growth over the forecast period. Advancements in the field of software technology, such as tracking surgical instruments and inventory management support the growth of this segment. For instance, IMPRESS, designed by BD helps delivering information on sterilized surgical equipment. This further facilitates inventory management and delivers ongoing assistance through phone.

The hardware segment is expected to showcase significant growth over the forecast period. This is due to the high demand for RFID labels and barcode tags. For instance, Dot XXS - Autoclavable Version of Xerafy is especially designed for tagging surgical instruments. It is one of the smallest RFID metal tag and withstands repeated autoclave and chemical washes.

Technology Insights

Barcode technology held the largest market share in 2016. It is the most common technology used for tracking systems and is widely used by medical device industry, thus, contributing to the growth of this segmental revenue. Moreover, the low installation cost associated with these barcodes also has led to increasing use by ambulatory surgery centers and hospitals.

The RFID segment is expected to witness lucrative CAGR over the forecast period owing to the rapid technological advancements in the field of RFID, such as huge data storage capacity, high durability, no requirement of line-of-sight and reusability.

End-Use Insights

In 2016, hospitals held the largest market share owing to the retention of surgical instruments at the site of surgery. In order to improve patient safety by tracking the instruments and managing the inventory, hospitals increasingly use surgical instrument tracking systems. This contributed to the growth of the segment.

Hospitals are also anticipated to show highest growth over the forecast period. Rapid technological advancements in the hardware and software is expected to support the growth of this segment.

Regional Insights

In 2016, North America held the largest market share. The U.S. Food and Drug Administration launched an innovative device, which can detect and identify medical devices. This factor contributed to this largest revenue growth. In addition, availability of highly developed medical infrastructure, huge penetration of advanced technology and rising healthcare expenditure further accelerates the growth of this regional segment. According to CMS, total healthcare spending in the U.S. was USD 3.2 trillion in 2015, which depicted high healthcare expenditure in this country.

Asia pacific is projected to witness attractive growth over the forecast period owing to the untapped market of this region. Moreover, rapid investments in healthcare infrastructure along with increasing geriatric population also contributed to the high growth of this segment.

Competitive Insights

Some of the major companies of this market are Xerafy; Haldor Advanced Technologies Ltd.; Materials Management Microsystems, Inc; Censis Technologies Inc.; Becton, Dickinson and Company and B. Braun Melsungen AG.

In order to fulfil the unmet needs of the target population, the major companies are undertaking regional expansion, development of new products and mergers & acquisitions. For instance, in October 2015, Xerafy launched world’s smallest RFID tag named XXS Tags.

Market Segment:

Product Outlook (Revenue, USD Million; 2014 - 2025)
        • Hardware
        • Software
        • Services

Technology Outlook (Revenue, USD Million; 2014 - 2025)
        • Barcodes
        • RFID

End-Use Outlook (Revenue, USD Million; 2014 - 2025)
        • Hospitals
        • Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)
        • North America
            • U.S.
            • Canada
        • Europe
            • Germany
            • UK
        • Asia Pacific
            • China
            • India
        • Latin America
            • Brazil
            • Mexico
        • MEA
            • South Africa

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/surgical-instrument-tracking-systems-market/request-sample

Location: Ostenring 22, 93358 Train, Germany

Comments

Post a Comment

Popular posts from this blog

Thermal Interface Materials Market Revenue, Share and Growth Rate to 2030

  The global thermal interface materials (TIMs) market size was estimated at USD 4.10 billion in 2024 and is projected to reach USD 7.89 billion by 2030, registering a strong CAGR of 11.6% from 2025 to 2030. Growth in this market is primarily driven by the increasing adoption of consumer electronics such as smartphones, laptops, gaming systems, and wearable devices, which require efficient heat dissipation to maintain performance. Similarly, the rising use of industrial automation technologies in developing economies, combined with the growing disposable income of the middle-class population, is significantly boosting demand for TIMs. These materials are specifically engineered to be applied between two hard surfaces often between electronic components and heat sinks to facilitate efficient heat conduction, ensuring safe operation even as devices become smaller, faster, and more powerful. The diverse commercial availability of TIMs in multiple formats, including grea...
Read more

Advancing Hydrogen Production Through Next Generation Electrolyzer Technologies

  Electrolyzers are at the center of the global transition toward clean energy and decarbonization. By using electricity to split water into hydrogen and oxygen, electrolyzers enable the production of green hydrogen when powered by renewable sources such as solar and wind. As governments and industries seek alternatives to fossil fuels, electrolyzer technology is rapidly evolving to deliver higher efficiency, scalability, and cost effectiveness. Hydrogen produced through electrolysis offers significant potential for decarbonizing hard to abate sectors including heavy industry, transportation, and power generation. Unlike conventional hydrogen production methods that rely on natural gas reforming, electrolyzers provide a pathway to low carbon hydrogen, supporting climate goals and long term energy security. Technology Advancement Across Electrolyzer Several electrolyzer technologies are currently shaping the industry, each offering distinct advantages. Alkaline electrol...
Read more

Drug Discovery Outsourcing Driving Faster Innovation and Smarter R&D Strategies

  Drug discovery outsourcing has emerged as a strategic approach for pharmaceutical and biotechnology companies seeking to enhance efficiency, reduce costs, and accelerate innovation. As therapeutic research becomes increasingly complex, organizations are turning to specialized external partners to manage critical aspects of the discovery pipeline. By leveraging advanced technologies, global expertise, and scalable infrastructure, outsourcing has become a cornerstone of modern drug development strategies. The early stages of drug development require significant investment in target identification, lead optimization, preclinical testing, and regulatory documentation. Managing these processes internally can strain resources and extend development timelines. Drug discovery outsourcing allows companies to access experienced scientific teams, state of the art laboratories, and advanced analytical tools without bearing the full burden of capital expenditure. Benefits of Out...
Read more